U.S. market Closed. Opens in 16 hours 28 minutes

INGN | Inogen, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 8.69 - 9.10
52 Week Range 4.49 - 13.33
Beta 0.99
Implied Volatility 120.64%
IV Rank 52.17%
Day's Volume 218,986
Average Volume 200,567
Shares Outstanding 23,719,000
Market Cap 214,182,570
Sector Healthcare
Industry Medical - Devices
IPO Date 2014-02-14
Valuation
Profitability
Growth
Health
P/E Ratio -2.27
Forward P/E Ratio -11.43
EPS -3.97
1YR Price Target 24.00
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 834
Country USA
Website INGN
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. The majority of rental revenue comes from Medicare service reimbursement programs. Internationally, Inogen sells its products through distributors or large gas companies and home oxygen providers. Inogen generates the majority of its revenue in the United States.
*Chart delayed
Analyzing fundamentals for INGN we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see INGN Fundamentals page.

Watching at INGN technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on INGN Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙